Results 221 to 230 of about 81,308 (259)

FDA Requirements and Post-Marketing Studies

IRB: Ethics and Human Research, 1987
Hedy M. Ries, Gary B. Weiss, William J. Winslade   +2 more
openaire   +1 more source

PNS Post-Marketing Study

Case Medical Research, 2019
openaire   +1 more source

Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future

Therapeutic Advances in Drug Safety, 2020
Muaed Alomar, Ali M Tawfiq, Subish Palaian   +2 more
exaly  

Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience

Multiple Sclerosis Journal, 2020
Sandra Vukusic, Christina D Chambers, Myriam Benamor   +2 more
exaly  

Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance

Frontiers in Drug Safety and Regulation, 2022
Gianluca Trifirò, Salvatore Crisafulli, Crisafulli Salvatore   +2 more
exaly  

Safety Profile of Oxaliplatin in 3,687 Patients With Cancer in China: A Post-Marketing Surveillance Study

Frontiers in Oncology, 2021
Chengliang Zhang, Hanjun Sun, Zhang Chengliang   +2 more
exaly  

SVS Post-Market Registry Study

Case Medical Research, 2020
openaire   +1 more source

A Post-marketing Surveillance Study on Bacampicillin

1982
P.G. PRELLA, M. CIAMPINI, E. MICHELETTI
openaire   +1 more source

Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia

Vaccine, 2011
Peter Mcintyre, Robert Booy, John B Carlin   +2 more
exaly  

Hemangiol, Post Marketing Surveillance Study

Case Medical Research, 2019
openaire   +1 more source